We are live on ! Find out more
CGIM

Capital Group Investment Management Portfolio holdings

AUM $585M
1-Year Est. Return 31.36%
This Fund
S&P 500
This Quarter Est. Return
-3.35%
1 Year Est. Return
+31.36%
3 Year Est. Return
+120.23%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$585M
AUM Growth
-$30.9M
Cap. Flow
+$10.6M
Cap. Flow %
1.81%
Top 10 Hldgs %
36.6%
Holding
150
New
11
Increased
61
Reduced
45
Closed
10

Top Buys

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$19.1M
2
NVDA icon
NVIDIA
NVDA
+$4.93M
3
APH icon
Amphenol
APH
+$4.24M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$4.13M
5
CDNS icon
Cadence Design Systems
CDNS
+$2.6M

Top Sells

Rank Stock Value
1
SNPS icon
Synopsys
SNPS
+$5.05M
2
FLUT icon
Flutter Entertainment
FLUT
+$3.69M
3
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$2.85M
4
CB icon
Chubb
CB
+$2.81M
5
AVGO icon
Broadcom
AVGO
+$2.71M

Sector Composition

Rank Sector Weight
1 Technology 24.06%
2 Healthcare 16.29%
3 Consumer Discretionary 15.05%
4 Communication Services 12.59%
5 Industrials 10.77%

No holdings matched the selected filter criteria.

2 3 4 5 6

Similar funds

TAM
Talos Asset Management New York $585M AUM 204.8% 1-Year Est. Return
GIM
Garden Investment Management Greenwich, Connecticut $586M AUM 15.35% 1-Year Est. Return
AIM
Arcadia Investment Management Kalamazoo, Michigan $584M AUM 21.44% 1-Year Est. Return
CC
Converium Capital Montreal $586M AUM
FMI
Frec Markets Inc San Francisco, California $587M AUM
PFG
Premier Financial Group Eureka, California $587M AUM 21.88% 1-Year Est. Return
MC
Martin & Co Knoxville, Tennessee $587M AUM 16.39% 1-Year Est. Return
IIA
IPG Investment Advisors San Diego, California $582M AUM 33.22% 1-Year Est. Return

Capital Group Investment Management's Q1 2026 Portfolio in Review

As of Q1 2026, Capital Group Investment Management held 150 positions worth $585M, down 5% from $616M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Capital Group Investment Management's Q1 2026 filing shows 11 new, 61 increased, 45 reduced and 10 closed positions. Its largest new stake was AstraZeneca: 99,013 shares worth $19.3M. The largest sale was Synopsys, an estimated $5.05M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Capital Group Investment Management's largest Q1 2026 buy was AstraZeneca: 99,013 shares worth $19.3M.
  • Capital Group Investment Management added most to NVIDIA in Q1 2026, an estimated $4.93M increase.
  • Capital Group Investment Management's biggest Q1 2026 reduction was Alnylam Pharmaceuticals, cutting an estimated $2.85M.
  • Capital Group Investment Management fully exited Synopsys in Q1 2026, selling an estimated $5.05M.
  • Capital Group Investment Management's ten largest holdings make up 37% of its $585M portfolio in Q1 2026.
  • Capital Group Investment Management opened 11 new positions and closed 10 in Q1 2026.
  • Capital Group Investment Management's portfolio value fell 5% quarter-over-quarter to $585M.

Based on Capital Group Investment Management's 13F filing for Q1 2026, filed 13 May 2026.